Neurotrope, Inc. 4
4 · Neurotrope, Inc. · Filed Nov 21, 2016
Insider Transaction Report
Form 4
Neurotrope, Inc.NTRP
Wilke Susanne
Director
Transactions
- Conversion
Common Stock
2016-11-17+17,242→ 67,243 total - Conversion
Series B Convertible Preferred Stock
2016-11-17−16,667→ 0 totalExercise: $0.58→ Common Stock (16,667 underlying)
Footnotes (2)
- [F1]The Reporting Person's shares of Series B Convertible Preferred Stock were automatically converted into an aggregate of 17,242 shares of common stock. This includes 575 shares received by the Reporting Person as the result of a reduction in the conversion price from $0.60 per 1/100 of one share of Series B Convertible Preferred Stock to $0.58.
- [F2]The Series B Convertible Preferred Stock was convertible into common stock at any time and had no expiration date. Pursuant to the Certificate of Designation, Preferences and Rights of Series B Convertible Preferred Stock, as amended, the Series B Convertible Preferred Stock converted automatically on November 17, 2016.